compounded retatrutide FDA Warns Companies Over Retatrutide: What Healthcare Providers Should Know Glass Vial Retatrutide Compounded Injections
Description
doi: 10.1161/HYPERTENSIONAHA.113.00588 96 GaspariTLiuHWelungodaIHuYWiddopREKnudsenLBet al
Now considered a landmark in the GLP-1 field, the article listed Mojsov as the first author and Habener as the last, a position customarily reserved for the senior author (Couzin-Frankel 8 Sept 2023
[Content Brief] [3]
Ceasovschih A et al
